The treatment part of this Phase 1 clinical trial for kidney cancer is over, now we’re in the watching and waiting phase.

My husband, Ralph, is patient #3 in a first in human clinical trial for kidney cancer at NIH.  He was diagnosed with stage IV Kidney Cancer in 2014. His journey has been long and somewhat difficult. This is his 4th clinical trial and 8th treatment regime.

A little over a week ago he had new fighter T-cells infused.  These new T-cells are modified to identify and attack his tumor cells.  At least, that’s what they did in the lab.  We’re waiting to see if they behave like that in Ralph’s body.

He was released after 12 days in the hospital.  Overall, he did very well tolerating the treatment which included 13 doses of IL-2.  His team of about 20 doctors are very pleased and relieved.  They really did not think he could tolerate that many IL-2 treatments since his heart is compromised.  However, he was released on oxygen which is likely temporary and a result of the IL-2 treatment.

Over the next several weeks, we’ll continue to stay in the downtown Bethesda area which has great places to eat (and shop) all within walking distance to our hotel.  He’ll have follow-up visits at NIH to include lab work, etc.  After all, they want to keep a close eye on their patient and their experiment.

WHO WE ARE →

WHAT WE DO →

OUR STORIES →

THE KIDNEY CANCER COMMUNITY →

SCIENTIFIC ADVISORY BOARD →

KIDNEYCAN NEWS →

DONATE →

CONTACT →

Latest News

Shari Stonacek: So Many Reasons to Live

Shari Stonacek: So Many Reasons to Live

Shari Stonacek is living with Stage IV kidney cancer. She is pictured here (center) with her family from left to right: daughter Joycin, daughter Jasmin, son-in-law Jordan, daughter-in-law Rachel holding grandson Landon, son Justin, Shari, husband Troy, daughter Joslin holding granddaughter...

JOIN OUR COMMUNITY →

RAISING AWARENESS →

BE AN ADVOCATE →

KIDNEYCAN NEWS →

DONATE →

CONTACT →

Latest News

District Days 2021: Speaking with One Voice

District Days 2021: Speaking with One Voice

Our Ask: Fund Kidney Cancer Research We lose almost 40 people per day to kidney cancer in the United States. The need for research funding is urgent.For District Days, the kidney cancer community met with members of Congress all over the United States to ask for robust funding of kidney cancer...

FACING KIDNEY CANCER →

DIAGNOSIS →

BUILDING A CARE TEAM →

LEARN ABOUT CLINICAL TRIALS →

LIVING WELL WITH KIDNEY CANCER →

DONATE →

CONTACT →

Latest News

Shari Stonacek: So Many Reasons to Live

Shari Stonacek: So Many Reasons to Live

Shari Stonacek is living with Stage IV kidney cancer. She is pictured here (center) with her family from left to right: daughter Joycin, daughter Jasmin, son-in-law Jordan, daughter-in-law Rachel holding grandson Landon, son Justin, Shari, husband Troy, daughter Joslin holding granddaughter...

KCRS →

RESEARCH OPPORTUNITIES →

ADVOCATE WITH KIDNEYCAN →

KIDNEYCAN NEWS →

DONATE →

CONTACT →

Latest News

District Days 2021: Speaking with One Voice

District Days 2021: Speaking with One Voice

Our Ask: Fund Kidney Cancer Research We lose almost 40 people per day to kidney cancer in the United States. The need for research funding is urgent.For District Days, the kidney cancer community met with members of Congress all over the United States to ask for robust funding of kidney cancer...

SUPPORT OUR WORK →

FUNDRAISE FOR KIDNEYCAN →

DONATE →

CONTACT →

Latest News

Shari Stonacek: So Many Reasons to Live

Shari Stonacek: So Many Reasons to Live

Shari Stonacek is living with Stage IV kidney cancer. She is pictured here (center) with her family from left to right: daughter Joycin, daughter Jasmin, son-in-law Jordan, daughter-in-law Rachel holding grandson Landon, son Justin, Shari, husband Troy, daughter Joslin holding granddaughter...